Back to Results
First PageMeta Content
Health / Tuberculosis treatment / Treatment Action Group / Stop TB Partnership / Multi-drug-resistant tuberculosis / Extensively drug-resistant tuberculosis / Global Plan to Stop Tuberculosis / Tuberculosis / Medicine / Microbiology


TUBERCULOSIS RESEARCH AND DEVELOPMENT: 2013 Report on Tuberculosis Research Funding Trends, 2005–2012
Add to Reading List

Document Date: 2013-10-25 13:25:02

Open Document

File Size: 1,90 MB

Share Result on Facebook

City

Washington / D.C. / /

Company

Stop TB Partnership / Pfizer / Treatment Action Group / TB Diagnostics / Hollander Snow Studio Treatment Action Group / TB R&D Investments / TAG Treatment Action Group Treatment Action Group / /

Continent

Europe / /

Country

Russia / United States / Brazil / Moldova / United Kingdom / China / South Africa / India / /

Currency

USD / /

/

Event

Funding / Person Communication and Meetings / /

Facility

Barnard College / National Institute of Allergy / Kenyon College / /

/

IndustryTerm

policy makers / /

MedicalCondition

cuts / TB / HIV / AIDS / Select Infectious Diseases / infections / tuberculosis / /

Organization

Melinda Gates Foundation / National Institute of Allergy and Infectious Diseases / National Institute of Health / U.S. Congress / Kenyon College / Barnard College / Moldovan hospital / Harvard School of Public Health / /

Person

Oxana Rucsineanu / Mark Harrington / ELEONORA JIMÉNEZ / MIKE FRICK / Pavel Rucsineanu / /

/

Position

senior researcher / Executive / project officer / /

Product

linezolid / /

Technology

drug discovery / diagnostic tests / /

URL

www.treatmentactiongroup.org / /

SocialTag